In addition to immune evasion, CXCR4 also contributes to chemoresistance and radioresistance by promoting DNA repair mechanisms and survival signaling in lung cancer cells, reducing the efficacy of conventional therapies (Césaire et al., 2022). Here, CXCR4 is linked to lung carcinoma.